Benefits from antidepressants: Synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine

Robert D. Gibbons*, Kwan Hur, C. Hendricks Brown, John M. Davis, J. John Mann

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

201 Scopus citations

Fingerprint

Dive into the research topics of 'Benefits from antidepressants: Synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine'. Together they form a unique fingerprint.

Medicine & Life Sciences

Arts & Humanities